Condensed Consolidated Statements of Cash Flows (USD $)	9 Months Ended
	Dec. 31, 2011	Dec. 31, 2010
Cash flows from operating activities:
Net loss	$ (3,614,095)	$ (8,105,129)
Depreciation and amortization	13,858	14,301
Stock based compensation	609,503	1,599,915
Loss on debt extinguishment		3,189,942
Fair market value of conditional warrants that subsequently were issued		74,652
Non cash interest expense	538,736	1,696,055
Fair market value of common stock, warrants and options issued for services	328,327	590,734
Change in fair value of derivative liabilities	(1,596,442)	(2,098,954)
Issuance of note in convertible note termination	360,186
Amortization of debt discount and deferred financing costs	1,703,219	1,301,014
Changes in operating assets and liabilities:
Accounts receivable	(183,367)
Prepaid expenses and other assets	10,557	52,260
Accounts payable and other current liabilities	728,432	152,246
Due to related parties		20,000
Net cash used in operating activities	(1,101,086)	(1,512,964)
Cash flows from investing activities:
Purchases of property and equipment	(1,735)	(2,541)
Additions to patents and patents pending		(6,805)
Net cash used in investing activities	(1,735)	(9,346)
Cash flows from financing activities:
Principal repayments of notes payable	(15,000)
Net proceeds from the issuance of convertible notes payable	1,256,921	1,105,000
Proceeds from the issuance of common stock		283,600
Proceeds from collection of secured notes receivable	200,000	300,000
Net cash provided by financing activities	1,441,921	1,688,600
Net increase in cash	339,100	166,290
Cash at beginning of period	15,704	67,950
Cash at end of period	354,804	234,240
Cash paid during the period for:
Interest	3,636
Income taxes
Derivative liabilities recorded in connection with embedded conversion feature of convertible notes and/or warrants		6,980,347
Debt and accrued interest converted to common stock	1,812,386	1,075,550
Debt discount recorded in connection with beneficial conversion feature of convertible notes and related warrants	1,037,901	1,708,600
Issuance of convertible notes in settlement of accrued legal fees		35,469
Reclassification of warrant derivative liability into equity	263,689
Issuance of shares in connection with restricted stock grant to officer		$ 600